• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Increased RNAi is related to intracellular release of siRNA via a covalently attached signal peptide.RNA干扰增强与通过共价连接的信号肽实现的小干扰RNA的细胞内释放有关。
RNA. 2009 Apr;15(4):627-36. doi: 10.1261/rna.1305209. Epub 2009 Feb 18.
2
Phosphorothioate-stimulated cellular uptake of siRNA: a cell culture model for mechanistic studies.硫代磷酸酯刺激的小干扰RNA的细胞摄取:用于机制研究的细胞培养模型
Curr Pharm Des. 2008;14(34):3666-73. doi: 10.2174/138161208786898770.
3
Cellular uptake and intracellular release are major obstacles to the therapeutic application of siRNA: novel options by phosphorothioate-stimulated delivery.细胞摄取和细胞内释放是小干扰RNA(siRNA)治疗应用的主要障碍:硫代磷酸酯刺激递送的新选择。
Expert Opin Biol Ther. 2007 Oct;7(10):1531-8. doi: 10.1517/14712598.7.10.1531.
4
Phosphorothioate-stimulated uptake of siRNA by mammalian cells: a novel route for delivery.硫代磷酸酯刺激的哺乳动物细胞摄取 siRNA:一种新型的递送途径。
Curr Top Med Chem. 2009;9(12):1109-16. doi: 10.2174/156802609789630884.
5
Dual Strategies Based on Golgi Apparatus/Endoplasmic Reticulum Targeting and Anchoring for High-Efficiency siRNA Delivery and Tumor RNAi Therapy.基于高尔基体/内质网靶向与锚定的双重策略用于高效小干扰RNA递送及肿瘤RNA干扰治疗
ACS Nano. 2025 Jan 28;19(3):3791-3806. doi: 10.1021/acsnano.4c14778. Epub 2025 Jan 12.
6
Visualizing a correlation between siRNA localization, cellular uptake, and RNAi in living cells.观察活细胞中siRNA定位、细胞摄取与RNA干扰之间的相关性。
Chem Biol. 2004 Aug;11(8):1165-75. doi: 10.1016/j.chembiol.2004.06.006.
7
Cellular delivery of small interfering RNA by a non-covalently attached cell-penetrating peptide: quantitative analysis of uptake and biological effect.通过非共价连接的细胞穿透肽进行小分子干扰RNA的细胞递送:摄取和生物学效应的定量分析
Nucleic Acids Res. 2006;34(22):6561-73. doi: 10.1093/nar/gkl941. Epub 2006 Nov 28.
8
Visible light-switched cytosol release of siRNA by amphiphilic fullerene derivative to enhance RNAi efficacy in vitro and in vivo.两亲性富勒烯衍生物介导的可见光开关型siRNA胞质释放以增强体内外RNA干扰效果
Acta Biomater. 2017 Sep 1;59:158-169. doi: 10.1016/j.actbio.2017.05.031. Epub 2017 May 13.
9
Enhancement of gene silencing effect and membrane permeability by Peptide-conjugated 27-nucleotide small interfering RNA.肽偶联 27 个核苷酸小干扰 RNA 增强基因沉默效果和膜通透性。
Molecules. 2012 Sep 14;17(9):11089-102. doi: 10.3390/molecules170911089.
10
Photoinduced RNA interference.光诱导 RNA 干扰。
Acc Chem Res. 2012 Jul 17;45(7):1039-47. doi: 10.1021/ar200227n. Epub 2012 Feb 24.

引用本文的文献

1
Evolution of complexity in non-viral oligonucleotide delivery systems: from gymnotic delivery through bioconjugates to biomimetic nanoparticles.非病毒寡核苷酸递药系统复杂性的演变:从巧妙递药到生物缀合物再到仿生纳米颗粒。
RNA Biol. 2022 Jan;19(1):1256-1275. doi: 10.1080/15476286.2022.2147278.
2
Suppression of chronic inflammation with engineered nanomaterials delivering nuclear factor κB transcription factor decoy oligodeoxynucleotides.利用递送核因子κB转录因子诱饵寡脱氧核苷酸的工程纳米材料抑制慢性炎症
Drug Deliv. 2017 Nov;24(1):1249-1261. doi: 10.1080/10717544.2017.1370511.
3
Functional peptides for siRNA delivery.用于小干扰RNA递送的功能性肽。
Adv Drug Deliv Rev. 2017 Feb;110-111:157-168. doi: 10.1016/j.addr.2016.08.004. Epub 2016 Aug 13.
4
Therapeutic Oligonucleotides Targeting Liver Disease: TTR Amyloidosis.靶向肝脏疾病的治疗性寡核苷酸:转甲状腺素蛋白淀粉样变性
Molecules. 2015 Sep 30;20(10):17944-75. doi: 10.3390/molecules201017944.
5
A bioreducible polymer for efficient delivery of Fas-silencing siRNA into stem cell spheroids and enhanced therapeutic angiogenesis.一种可还原的聚合物,可有效将 Fas 沉默 siRNA 递送至干细胞球体,并增强治疗性血管生成。
Angew Chem Int Ed Engl. 2012 Nov 19;51(47):11899-903. doi: 10.1002/anie.201206595. Epub 2012 Oct 16.
6
Enhancement of gene silencing effect and membrane permeability by Peptide-conjugated 27-nucleotide small interfering RNA.肽偶联 27 个核苷酸小干扰 RNA 增强基因沉默效果和膜通透性。
Molecules. 2012 Sep 14;17(9):11089-102. doi: 10.3390/molecules170911089.
7
Cell-specific RNA interference by peptide-inhibited-peptidase-activated siRNAs.肽抑制肽酶激活的小干扰RNA介导的细胞特异性RNA干扰
J RNAi Gene Silencing. 2010 Dec 31;6(2):422-30.
8
Cell stress is related to re-localization of Argonaute 2 and to decreased RNA interference in human cells.细胞应激与 Argonaute 2 的重新定位以及人细胞中 RNA 干扰的减少有关。
Nucleic Acids Res. 2011 Apr;39(7):2727-41. doi: 10.1093/nar/gkq1216. Epub 2010 Dec 8.
9
Antisense tools for functional studies of human Argonaute proteins.用于人类 Argonaute 蛋白功能研究的反义工具。
RNA. 2010 Dec;16(12):2529-36. doi: 10.1261/rna.2204610. Epub 2010 Oct 8.
10
Biological barriers to therapy with antisense and siRNA oligonucleotides.反义寡核苷酸和小干扰RNA寡核苷酸治疗的生物学障碍。
Mol Pharm. 2009 May-Jun;6(3):686-95. doi: 10.1021/mp900093r.

本文引用的文献

1
Disulfide conjugation of peptides to oligonucleotides and their analogs.肽与寡核苷酸及其类似物的二硫键共轭。
Curr Protoc Nucleic Acid Chem. 2006 Apr;Chapter 4:Unit 4.28. doi: 10.1002/0471142700.nc0428s24.
2
Cell penetrating peptide conjugates of steric block oligonucleotides.空间位阻寡核苷酸的细胞穿透肽缀合物
Adv Drug Deliv Rev. 2008 Mar 1;60(4-5):517-29. doi: 10.1016/j.addr.2007.09.002. Epub 2007 Oct 22.
3
Delivery of proteins and nucleic acids using a non-covalent peptide-based strategy.使用基于非共价肽的策略递送蛋白质和核酸。
Adv Drug Deliv Rev. 2008 Mar 1;60(4-5):537-47. doi: 10.1016/j.addr.2007.09.005. Epub 2007 Oct 25.
4
Expanding the repertoire of RNA interference screens for developing new anticancer drug targets.拓展RNA干扰筛选库以开发新的抗癌药物靶点。
Expert Opin Ther Targets. 2007 Nov;11(11):1429-41. doi: 10.1517/14728222.11.11.1429.
5
Cellular uptake and intracellular release are major obstacles to the therapeutic application of siRNA: novel options by phosphorothioate-stimulated delivery.细胞摄取和细胞内释放是小干扰RNA(siRNA)治疗应用的主要障碍:硫代磷酸酯刺激递送的新选择。
Expert Opin Biol Ther. 2007 Oct;7(10):1531-8. doi: 10.1517/14712598.7.10.1531.
6
Interfering with disease: a progress report on siRNA-based therapeutics.干预疾病:基于小干扰RNA疗法的进展报告
Nat Rev Drug Discov. 2007 Jun;6(6):443-53. doi: 10.1038/nrd2310.
7
Illuminating the silence: understanding the structure and function of small RNAs.揭示沉默:了解小RNA的结构与功能
Nat Rev Mol Cell Biol. 2007 Jan;8(1):23-36. doi: 10.1038/nrm2085.
8
RNA targeting with peptide conjugates of oligonucleotides, siRNA and PNA.使用寡核苷酸、小干扰RNA和肽核酸的肽缀合物进行RNA靶向
Blood Cells Mol Dis. 2007 Jan-Feb;38(1):1-7. doi: 10.1016/j.bcmd.2006.10.003. Epub 2006 Nov 17.
9
RNAi therapeutics: a potential new class of pharmaceutical drugs.RNA干扰疗法:一类潜在的新型药物。
Nat Chem Biol. 2006 Dec;2(12):711-9. doi: 10.1038/nchembio839.
10
RNA interference-mediated gene silencing of pleiotrophin through polyethylenimine-complexed small interfering RNAs in vivo exerts antitumoral effects in glioblastoma xenografts.通过聚乙烯亚胺复合小干扰RNA在体内对多效生长因子进行RNA干扰介导的基因沉默,可对胶质母细胞瘤异种移植瘤发挥抗肿瘤作用。
Hum Gene Ther. 2006 Jul;17(7):751-66. doi: 10.1089/hum.2006.17.751.

RNA干扰增强与通过共价连接的信号肽实现的小干扰RNA的细胞内释放有关。

Increased RNAi is related to intracellular release of siRNA via a covalently attached signal peptide.

作者信息

Detzer Anke, Overhoff Marita, Wünsche Winfried, Rompf Maria, Turner John J, Ivanova Gabriela D, Gait Michael J, Sczakiel Georg

机构信息

Institut für Molekulare Medizin, Universität zu Lübeck and Schleswig-Holstein, Germany.

出版信息

RNA. 2009 Apr;15(4):627-36. doi: 10.1261/rna.1305209. Epub 2009 Feb 18.

DOI:10.1261/rna.1305209
PMID:19228587
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2661840/
Abstract

In the last decade short interfering RNA (siRNA) became an important means for functional genomics and the development of gene-specific drugs. However, major technical hurdles in the application of siRNA include its cellular delivery followed by its intracellular trafficking and its release in order to enter the RNA interference (RNAi) machinery. The novel phosphorothioate-stimulated cellular uptake of siRNA contrasts other known delivery systems because it involves a caveosomal pathway in which large amounts of siRNA are delivered to the perinuclear environment, leading to measurable though moderate target suppression. Limited efficacy seems to be related to intracellular trapping of siRNA. To study the role of intracellular trafficking of siRNA for biological effectiveness we studied whether a signal peptide for trans-membrane transport of bacterial protein toxins, which is covalently attached to siRNA, can promote its release from the perinuclear space into the cytoplasm and thereby enhance its biological effectiveness. We show that attachment of the peptide TQIENLKEKG to lamin A/C-directed siRNA improves target inhibition after its PS-stimulated delivery. This is related to increased efflux of the siRNA-peptide conjugate from the ER-specific perinuclear sites. In summary, this study strongly suggests that intracellular release of siRNA leads to increased biological effectiveness. Thus covalent peptide-siRNA conjugates are proposed as new tools to study the relationship between intracellular transport and efficacy of siRNA.

摘要

在过去十年中,短干扰RNA(siRNA)成为功能基因组学和基因特异性药物研发的重要手段。然而,siRNA应用中的主要技术障碍包括其细胞递送,随后是细胞内运输及其释放,以便进入RNA干扰(RNAi)机制。新型硫代磷酸酯刺激的siRNA细胞摄取与其他已知递送系统不同,因为它涉及一种小窝体途径,大量siRNA被递送至核周环境,导致可测量但适度的靶标抑制。有限的疗效似乎与siRNA的细胞内滞留有关。为了研究siRNA的细胞内运输对生物学有效性的作用,我们研究了与siRNA共价连接的细菌蛋白毒素跨膜运输信号肽是否能促进其从核周空间释放到细胞质中,从而增强其生物学有效性。我们表明,将肽TQIENLKEKG连接到针对核纤层蛋白A/C的siRNA上,在PS刺激递送后可改善靶标抑制。这与siRNA-肽缀合物从内质网特异性核周位点的流出增加有关。总之,这项研究强烈表明,siRNA的细胞内释放会导致生物学有效性增加。因此,共价肽-siRNA缀合物被提议作为研究siRNA细胞内运输与疗效之间关系的新工具。